CHRISTINE SMILEY: Open Payments
NPI 1811029499 · DAYVILLE, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$208 in 5 payments from 5 companies in 2025. Trend: 2023 $711 · 2024 $35 · 2025 $208
Food & beverage: $208
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $119 |
| Vanda Pharmaceuticals Inc. | 1 | $25 |
| E.R. Squibb & Sons, L.L.C. | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Neurocrine BioSciences, Inc. | 1 | $19 |
Products named: CAPLYTA, FANAPT, COBENFY, REXULTI, INGREZZA.
Industry payments across CT — which companies pay providers there.
